Paton C - Search Results

1

Joint BAP NAPICU evidence-based consensus guidelines for the clinical management of acute disturbance: De-escalation and rapid tranquillisation.

Patel MX, Sethi FN, Barnes TR, Dix R, Dratcu L, Fox B, Garriga M, Haste JC, Kahl KG, Lingford-Hughes A, McAllister-Williams H, O'Brien A, Parker C, Paterson B, Paton C, Posporelis S, Taylor DM, Vieta E, Völlm B, Wilson-Jones C, Woods L; With co-authors (in alphabetical order):. Patel MX, et al. Among authors: paton c. J Psychopharmacol. 2018 Jun;32(6):601-640. doi: 10.1177/0269881118776738. Epub 2018 Jun 8. J Psychopharmacol. 2018. PMID: 29882463

2

Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review.

Taylor DM, Young C, Paton C. Taylor DM, et al. Among authors: paton c. J Clin Psychiatry. 2003 Jan;64(1):30-4. doi: 10.4088/jcp.v64n0107. J Clin Psychiatry. 2003. PMID: 12590620

3

Patterns of antipsychotic and anticholinergic prescribing for hospital inpatients.

Paton C, Lelliott P, Harrington M, Okocha C, Sensky T, Duffett R. Paton C, et al. J Psychopharmacol. 2003 Jun;17(2):223-9. doi: 10.1177/0269881103017002012. J Psychopharmacol. 2003. PMID: 12870571

4

Testing for diabetes in hospitalised patients prescribed antipsychotic drugs.

Taylor D, Young C, Esop R, Paton C, Walwyn R. Taylor D, et al. Among authors: paton c. Br J Psychiatry. 2004 Aug;185:152-6. doi: 10.1192/bjp.185.2.152. Br J Psychiatry. 2004. PMID: 15286067

5

Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs.

Paton C, Esop R, Young C, Taylor D. Paton C, et al. Acta Psychiatr Scand. 2004 Oct;110(4):299-305. doi: 10.1111/j.1600-0447.2004.00372.x. Acta Psychiatr Scand. 2004. PMID: 15352932

6

Undiagnosed impaired fasting glucose and diabetes mellitus amongst inpatients receiving antipsychotic drugs.

Taylor D, Young C, Mohamed R, Paton C, Walwyn R. Taylor D, et al. Among authors: paton c. J Psychopharmacol. 2005 Mar;19(2):182-6. doi: 10.1177/0269881105049039. J Psychopharmacol. 2005. PMID: 15728440 Clinical Trial.

7

Augmentation with a second antipsychotic in patients with schizophrenia who partially respond to clozapine: a meta-analysis.

Paton C, Whittington C, Barnes TR. Paton C, et al. J Clin Psychopharmacol. 2007 Apr;27(2):198-204. doi: 10.1097/JCP.0b013e318036bfbb. J Clin Psychopharmacol. 2007. PMID: 17414246

8

A UK audit of screening for the metabolic side effects of antipsychotics in community patients.

Barnes TR, Paton C, Cavanagh MR, Hancock E, Taylor DM; UK Prescribing Observatory for Mental Health. Barnes TR, et al. Among authors: paton c. Schizophr Bull. 2007 Nov;33(6):1397-403. doi: 10.1093/schbul/sbm038. Epub 2007 May 4. Schizophr Bull. 2007. PMID: 17483101 Free PMC article.

9

Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration.

Yusufi B, Mukherjee S, Flanagan R, Paton C, Dunn G, Page E, Barnes TR. Yusufi B, et al. Among authors: paton c. Int Clin Psychopharmacol. 2007 Jul;22(4):238-43. doi: 10.1097/YIC.0b013e32819f8f17. Int Clin Psychopharmacol. 2007. PMID: 17519648

10

Informing patients of the teratogenic potential of mood stabilizing drugs: a case note review of the practice of psychiatrists.

James L, Barnes TR, Lelliott P, Taylor D, Paton C. James L, et al. Among authors: paton c. J Psychopharmacol. 2007 Nov;21(8):815-9. doi: 10.1177/0269881107077222. Epub 2007 Sep 19. J Psychopharmacol. 2007. PMID: 17881432

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

406 results

Search Page

Filters